Literature DB >> 26497526

The multiple facets of FcRn in immunity.

Nigel M Stapleton1, Helga K Einarsdóttir1, Annette M Stemerding2, Gestur Vidarsson1.   

Abstract

The neonatal Fc receptor, FcRn, is best known for its role in transporting IgG in various tissues, providing newborns with humoral immunity, and for prolonging the half-life of IgG. Recent findings implicate the involvement of FcRn in a far wider range of biological and immunological processes, as FcRn has been found to bind and extend the half-life of albumin; to be involved in IgG transport and antigen sampling at mucosal surfaces; and to be crucial for efficient IgG-mediated phagocytosis. Herein, the function of FcRn will be reviewed, with emphasis on its recently documented significance for IgG polymorphisms affecting the half-life and biodistribution of IgG3, on its role in phagocyte biology, and the subsequent role for the presentation of antigens to lymphocytes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FcRn; half-life; myeloid cells; neonatal Fc receptor; phagocytosis

Mesh:

Substances:

Year:  2015        PMID: 26497526     DOI: 10.1111/imr.12331

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  39 in total

1.  Human Immunoglobulin Heavy Gamma Chain Polymorphisms: Molecular Confirmation Of Proteomic Assessment.

Authors:  Magalie Dambrun; Célia Dechavanne; Alexandra Emmanuel; Florentin Aussenac; Marjorie Leduc; Chiara Giangrande; Joëlle Vinh; Jean-Michel Dugoujon; Marie-Paule Lefranc; François Guillonneau; Florence Migot-Nabias
Journal:  Mol Cell Proteomics       Date:  2017-03-06       Impact factor: 5.911

2.  Conservation of sequence motifs suggests that the nonclassical MHC class I lineages CD1/PROCR and UT were established before the emergence of tetrapod species.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi; Unni Grimholt
Journal:  Immunogenetics       Date:  2017-12-21       Impact factor: 2.846

3.  IgG trafficking in the adult pig small intestine: one- or bidirectional transfer across the enterocyte brush border?

Authors:  Rebecca Möller; Gert H Hansen; E Michael Danielsen
Journal:  Histochem Cell Biol       Date:  2016-09-19       Impact factor: 4.304

4.  The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.

Authors:  Bianca Balbino; Pauline Herviou; Ophélie Godon; Julien Stackowicz; Odile Richard-Le Goff; Bruno Iannascoli; Delphine Sterlin; Sébastien Brûlé; Gael A Millot; Faith M Harris; Vera A Voronina; Kari C Nadeau; Lynn E Macdonald; Andrew J Murphy; Pierre Bruhns; Laurent L Reber
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.

Authors:  M Christian Tjiam; Mazmah A Morshidi; Lucy Sariputra; Jeffrey N Martin; Steven G Deeks; Dino B A Tan; Silvia Lee; Sonia Fernandez; Martyn A French
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

6.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

7.  Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns.

Authors:  Natalia A Lozano; Alejandro Lozano; Vanina Marini; Ricardo J Saranz; Richard S Blumberg; Kristi Baker; Maria F Agresta; Marina F Ponzio
Journal:  Am J Reprod Immunol       Date:  2018-05-10       Impact factor: 3.886

8.  Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis.

Authors:  Alexis Vogelzang; Laura Lozza; Stephen T Reece; Carolina Perdomo; Ulrike Zedler; Karin Hahnke; Dagmar Oberbeck-Mueller; Anca Dorhoi; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 9.  Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins.

Authors:  Chiara Elisabeth Geyer; Lynn Mes; Melissa Newling; Jeroen den Dunnen; Willianne Hoepel
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

Review 10.  Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy.

Authors:  Seung Hyun Kang; Chang-Han Lee
Journal:  Biotechnol Bioprocess Eng       Date:  2021-06-28       Impact factor: 2.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.